$502 Million is the total value of HIGHLAND ASSOCIATES INC's 6 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 500.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VT | Sell | Vanguard Intl Equity Index Fundtt world st etf | $466,934,017,000 | -4.6% | 6,634,100 | -0.1% | 92.93% | -7.1% |
VRTX | New | VERTEX PHARMACEUTICALS INC | $8,158,080,000 | – | 48,000 | +100.0% | 1.62% | – |
AIV | New | APARTMENT INVT & MGMT COcl a | $7,119,386,000 | – | 168,307 | +100.0% | 1.42% | – |
LUV | New | SOUTHWEST AIRLS CO | $7,016,352,000 | – | 137,900 | +100.0% | 1.40% | – |
BLK | New | BLACKROCK INC | $6,672,165,000 | – | 13,370 | +100.0% | 1.33% | – |
DFS | New | DISCOVER FINL SVCS | $6,534,048,000 | – | 92,800 | +100.0% | 1.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 4 | Q2 2019 | 75.3% |
ISHARES TR | 4 | Q2 2019 | 4.9% |
Vanguard Intl Equity Index Fund | 3 | Q2 2018 | 100.0% |
CELGENE CORP | 2 | Q2 2019 | 3.1% |
VERTEX PHARMACEUTICALS INC | 2 | Q3 2018 | 1.6% |
Vanguard INTL Equity Index Fund | 1 | Q4 2017 | 95.2% |
ALPHABET INC | 1 | Q2 2019 | 7.3% |
United Technologies Corp | 1 | Q4 2018 | 6.9% |
GILEAD SCIENCES INC | 1 | Q2 2019 | 6.0% |
Wynn Resorts Ltd | 1 | Q4 2018 | 4.8% |
View HIGHLAND ASSOCIATES INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2019-08-08 |
13F-HR | 2019-04-30 |
13F-HR | 2019-01-15 |
13F-HR | 2018-10-22 |
13F-HR | 2018-08-06 |
13F-HR | 2018-04-06 |
13F-HR | 2018-01-24 |
40-APP/A | 2012-10-16 |
40-APP/A | 2012-09-20 |
40-APP/A | 2012-07-20 |
View HIGHLAND ASSOCIATES INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.